Company Search:
Advanced Search
Sponsored Links
PhaseBio Pharmaceuticals Inc Company Snapshot
PhaseBio Pharmaceuticals Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares PhaseBio Pharmaceuticals Inc with three other companies in this sector in UNITED STATES : Northwest Biotherapeutics, Inc. (2019 sales of $2.41 million ), Synlogic Inc ($2.22 million of which 100% was Discovery and development of synthetic b), and Adocia SA ($2.40 million of which 100% was Regenerative Medicine).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
PhaseBio Pharmaceuticals Inc
  Stock Performance Chart for PhaseBio Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/20/2020): 3.53
(Figures in U.S. Dollars)
1 Week -3.6%   13 Weeks 14.1%  
4 Weeks -6.9%   52 Weeks 1.7%  
PhaseBio Pharmaceuticals Inc Key Data:
  Ticker: PHAS Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 2,361,000
(Year Ending Jan 2020).
Employees: 40
  Currency: U.S. Dollars Market Cap: 103,638,403
  Fiscal Yr Ends: December Shares Outstanding: 29,359,321
  Share Type: Common Closely Held Shares: 3,281,458
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.